Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» EMA
EMA
European Drug Agency Delays Trial-Data Policy Until March
Bloomberg
Tue, 12/17/13 - 02:36 pm
clinical trial data
EMA
Europe
Pharma Blasts EMA Draft Policy On Disclosing Clinical Trial Data
Pharmalot
Mon, 09/9/13 - 10:40 am
clinical trial data
clinical trials
EMA
Simultaneous Applications Submitted to EMA and FDA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
Reuters
Tue, 09/3/13 - 10:43 am
EMA
FDA
siltuximab
multicentric Castleman disease
AbbVie seeks to stop EU agency releasing drug data
Reuters
Mon, 03/11/13 - 10:46 am
AbbVie
drug data
EMA
Europe
Novartis gets EMA nod for Jetrea
FiercePharma
Sat, 01/19/13 - 12:14 pm
Novartis
EMA
Jetrea
regulatory
Novartis wins EU okay for first meningitis B vaccine
Reuters
Fri, 11/16/12 - 10:12 am
Novartis
EMA
Europe
meningitis B
vaccines
Bexsero
J&J eyes new Doxil process to reverse shortage
Fierce Pharma
Tue, 10/9/12 - 11:16 am
Doxil
JNJ
drug shortages
FDA
EMA
EU body wants new guidance on Boehringer clot drug
Reuters
Fri, 05/25/12 - 10:01 am
bloodthinners
Pradaxa
Boehringer Ingelheim
Europe
EMA
Novartis’s Gilenya Reviewed After 11 Deaths
Bloomberg
Fri, 01/20/12 - 10:06 am
Novartis
Gilenya
MS
multiple sclerosis
EMA
SkyePharma Shares Fall After Flutiform Application Fails to Win Consensus
Bloomberg
Fri, 12/23/11 - 08:52 am
SkyePharma
EMA
Europe
Flutiform
asthma
Celsion Completes Consultative Review Process With EMA for Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer
Mon, 12/19/11 - 06:05 pm
Celsion
EMA
ThermoDox
hepatocellular carcinoma
liver cancer
radio frequency ablation
Roche melanoma drug wins European green light
Reuters
Fri, 12/16/11 - 10:30 am
Roche
melanoma
Europe
EMA
Zelboraf
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Motley Fool
Fri, 11/18/11 - 11:39 am
EMA
AstraZeneca
medullary thyroid cancer
vandetanib
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
Fri, 11/11/11 - 01:04 pm
FDA
EMA
overactive bladder
Astellas
mirabegron
Europe Calls for Limits on Sanofi's Multaq
Motley Fool
Fri, 09/23/11 - 11:59 am
Sanofi
Multaq
Europe
EMA
EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
Bloomberg
Thu, 07/21/11 - 12:09 pm
Pfizer
Champix
EMA
Europe
smoking cessation
As Advair Sales Erode, Benlysta Gets EMA Nod
Motley Fool
Fri, 07/15/11 - 01:02 am
Advair
Benlysta
EMA
GSK
Human Genome Sciences
lupus
EMA Recommends Approval for Pfizer, Bristol-Myers’ Eliquis
Bloomberg
Fri, 03/18/11 - 10:22 am
EMA
Europe
Eliquis
Pfizer
blood thinners
Apixaban
FDA, EMA move against Avastin for breast cancer
Fierce Pharma
Thu, 12/16/10 - 12:43 pm
FDA
EMA
Avastin
breast cancer
Roche
Growth Hormone in Pfizer, Roche Drugs Gets EMA Review
Bloomberg
Thu, 12/16/10 - 12:42 pm
Pfizer
Roche
EMA
somatropin
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »